[1. Sybilski AJ, Raciborski F, Lipiec A, et al. Atopic dermatitis is a serious health problem in Poland. Epidemiology studies based on the ECAP study. Postępy Dermatol Alergol. 2015;32(1):1-10.10.5114/pdia.2014.40935]Search in Google Scholar
[2. Odhiambo JA, Williams HC, Clayton TO, et al. ISAAC Phase Three Study Group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124(6):1251-1258.10.1016/j.jaci.2009.10.009]Search in Google Scholar
[3. Samoliński B, Raciborski F, Lipiec A, et al. Epidemiology of allergic diseases in Poland. Pol J Allergol. 2014;1:10-8.]Search in Google Scholar
[4. DuBuske L. Appropriate and inappropriate use of immunotherapy. Ann Allergy Asthma Immunol 2001; 87(Suppl): 56-67.10.1016/S1081-1206(10)62196-5]Search in Google Scholar
[5. Joint Task Force on Practice Parameters: Allergen immunotherapy: a practice parameter. Ann. Allergy Asthma Immunol. 2003; 90:1-40.10.1016/S1081-1206(10)63600-9]Search in Google Scholar
[6. Jutel M, Kowalski ML, Rogala B, et al. Swoista immunoterapia alergenowa. (w) Standardy w alergologii. Cz. I. Kruszewski J, Kowalski ML (red.). Kraków: Medycyna Praktyczna, wyd. II, 2010; 152-159.]Search in Google Scholar
[7. Kowalski ML, Buczyłko K, Jurkiewicz D, et al. Objawy niepożądane w przebiegu immunoterapii przedsezonowej preparatem Pollinex®+Rye u pacjentów uczulonych na pyłki drzew i/lub traw – badanie wieloośrodkowe. Alergia Astma Immunol. 2001; 6(1): 45-50.]Search in Google Scholar
[8. Kowalski ML, Jutel M. Mechanisms of specific immunotherapy of allergic diseases. Allergy. 1998; 52: 485-492.10.1111/j.1398-9995.1998.tb04085.x]Search in Google Scholar
[9. Kowalski ML. Systemic and specific treatment for a global disease: alergen immunotherapy revisited. Allergy 2006; 61(7): 791-795.10.1111/j.1398-9995.2006.01187.x16792575]Search in Google Scholar
[10. Kruszewski J (red.) Anafilaksja. Medycyna Praktyczna. Kraków, 2009.]Search in Google Scholar
[11. Fujita H, Soyka MB, Akdis CA. Mechanisms of alergen-specific immunotherapy. Clin Transl Allergy. 2012; 2(1): 2.10.1186/2045-7022-2-2339583322409879]Search in Google Scholar
[12. Alvarez-Cuesta E, Bousquet J, Canonica GW, et al. Standards for practical alergen-specific immunotherapy. Allergy 2006; 61 (Suppl. 82): 1-201.10.1111/j.1398-9995.2006.01219_1.x16930249]Search in Google Scholar
[13. Eifan AO, Shamji MH, Durham SR. Long-term clinical and immunological effects of alergen immunotherapy. Curr Opin Allergy Clin Immunol 2011; 11(6): 586-593.10.1097/ACI.0b013e32834cb99421986550]Search in Google Scholar
[14. Mosbech H, Osterballe O. Does the effect of immunotherapy last after termination of treatment? Allergy 1988; 43: 523.10.1111/j.1398-9995.1988.tb01631.x]Search in Google Scholar
[15. Rogala B. Risk and safety of immunotherapy. Allergy 1998; 53: 474-478.10.1111/j.1398-9995.1998.tb04083.x9636805]Search in Google Scholar
[16. Buczyłko K, Chwała C, Wagner A, et al. Porównanie klinicznej skuteczności całorocznego przedsezonowego odczulania alergii na pyłki traw preparatem Catalet T. Alergia Astma Immunol. 2000; 5(3): 183-187.]Search in Google Scholar
[17. Copenhaver CC, Parker A, Patch S. Systemic reactions with aeroallergen cluster immunotherapy in a clinical practice. Ann Allergy Asthma Immunol. 2011; 107(5): 441-445.10.1016/j.anai.2011.06.02622018617]Search in Google Scholar
[18. Zuberbier T, Bachert C, Bousquet PJ, et al. GA2LEN/EAACI pocketguide for alergen-specific immunotherapy for allergic rhinitic and asthma. Allergy 2010; 65: 1525-1530.10.1111/j.1398-9995.2010.02474.x21039596]Search in Google Scholar
[19. Światowa strategia rozpoznawania, leczenia i prewencji astmy. Raport NHLBI/WHO. Med. Prakt 2002; 6: 1-181.]Search in Google Scholar
[20. Passalacgua G, Duhram S. Specific Immunotherapy. J. Allergy Clin. Immunol. 2007; 119: 881-891.10.1016/j.jaci.2007.01.045]Search in Google Scholar
[21. Chyrek-Borowska S. Groźne dla życia objawy ogólne i narządowe w przebiegu immunoterapii swoistej i testów skórnych. [w] Stany zagrożenia życia w pneumonologii i alergologii. Płusa T (red.). Warszawa: Sanmedia, 1993; 92-98.]Search in Google Scholar
[22. Kruszewski J. Wstrząs anafilaktyczny. (w) Stany zagrożenia życia w pneumonologii i alergologii. Płusa T (red.). Warszawa: Sanmedia, 1993; 78-86.]Search in Google Scholar